دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش:
نویسندگان: Franck Billmann. Tobias Keck
سری:
ISBN (شابک) : 3662667347, 9783662667347
ناشر: Springer
سال نشر: 2023
تعداد صفحات: 391
[392]
زبان: English
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود)
حجم فایل: 22 Mb
در صورت تبدیل فایل کتاب Essentials of Visceral Surgery: For Residents and Fellows به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب ملزومات جراحی احشایی: برای دستیاران و دانشجویان نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
ویرایش دوم این کتاب موفق همچنین دانش واقعی جراحی احشایی را به صورت فشرده و کلیدواژهمانند خلاصه میکند. این برای آماده سازی برای معاینه تخصصی و همچنین برای مراجعه سریع در عمل بالینی روزمره مناسب است. تمامی مقالات توسط کارشناسان مشهور نوشته شده است. تمرکز بر توصیه های دقیق در مورد روش تشخیصی، اندیکاسیون و اجرای درمان است. برای مهم ترین مداخلات، مراحل عمل جراحی نیز ارائه شده است. مرورهای کوتاه، به خاطر سپردن هدفمند مهم ترین حقایق را تسهیل می کند.
The 2nd edition of the successful book also summarises the factual knowledge of visceral surgery in a condensed, keyword-like form. It is suitable for preparation for the specialist examination as well as for quick reference in everyday clinical practice. All articles have been written by renowned experts. The focus is on detailed recommendations on the diagnostic procedure, the indication and the implementation of therapy; for the most important interventions, the steps of the surgical procedure are also presented. Brief overviews facilitate the targeted memorisation of the most important facts.
Preface Contents Contributors Abbreviations 1: Esophagus, Stomach and Duodenum 1.1 Anatomy and Physiology 1.1.1 Esophagus 1.1.2 Stomach 1.1.3 Duodenum 1.2 Leading Symptoms and Diagnosis 1.2.1 Leading Symptoms Esophagus Stomach Upper GI Bleeding 1.2.2 Diagnosis Endoscopy Radiology/Nuclear Medicine 1.2.3 Therapeutic Principles 1.3 Benign Diseases of the Esophagus 1.3.1 Diverticular Diseases of the Esophagus Etiology Zenker’s Diverticulum and Epiphrenic Diverticulum (Pulsion Diverticulum) Midesophageal Diverticulum (Traction Diverticulum) Forms Zenker’s Diverticulum (Hypopharynx) Killian-Jamison Diverticulum Epiphrenic Diverticulum Symptoms Therapy Zenker-Diverikel Epiphrenic Diverticulum 1.3.2 Achalasia Etiology Pathogenesis Forms Primary Achalasia Secondary Achalasia Symptoms Complications Staging Diagnosis Esophagogastroduodenoscopy (EGD) Manometry X-Ray (Esophagogram)/Computed Tomography Therapy Medical Therapy Principle Preparations Endoscopic Therapy Pneumatic Dilatation Endoscopic Injection of Botulinum Toxin Peroral Endoscopic Myotomy (POEM) Surgical Therapy Surgical Therapy Options Results After Myotomy 1.3.3 Esophageal Perforation Etiology Symptoms Diagnosis Endoscopy (EGD) Computed Tomography of the chest Therapy Surgical Therapy Endoscopic Therapy Conservative Therapy Prognostic Factors 1.3.4 Hiatal Hernias Etiology Types of Hiatal Hernias (. Fig. 1.2) Cardiofundal Malposition Axial Sliding Hernia Paraesophageal Hernia Mixed Forms Symptoms Axial Hernias Paraesophageal Hernias Therapy Symptomatic Therapy Surgical Therapy 1.3.5 Gastroesophageal Reflux Disease (GERD) Definition Etiology Demographics Pathophysiology and Risk Factors Symptoms Diagnosis Esophagogastroduodenoscopy (EGD) 24 h pH-Metry/Impedance Measurement Manometry Therapy Conservative Therapy Surgical Therapy 1.3.6 Guidelines 1.4 Malignant Diseases of the Esophagus 1.4.1 Overview Esophageal Cancer Adenocarcinoma of the Gastroesophageal Junction (AEG) 1.4.2 Esophageal Carcinoma (Including AEG) Definition Types Adenocarcinoma Adenocarcinoma of the Gastroesophageal Junction (AEG) Squamous Cell Carcinoma Adenosquamous Carcinomas, Undifferentiated Carcinomas Epidemiology and Etiology Occurrence Risk Factors Squamous Cell Carcinoma Adenocarcinoma Tumor Spread Continuous Spread Lymphogenous Spread Hematogenous Spread Classification UICC/AJCC TNM 8 Classification (2017) UICC Stages According to the TNM Classification 8th Version (2017) Symptoms Diagnosis Esophagogastroduodenoscopy (EGD) Endosonography Thoracic CT, Abdominal CT Bronchoscopy Panendoscopy PET-CT, MRI Abdomen Therapy Indication Multimodal Therapy Principles Neoadjuvant Radiochemotherapy Perioperative Chemotherapy Additive/Palliative Therapy Principles Strategy Operative Therapy Principles Local Endoscopic Interventional Procedures Esophagectomy Prognostic Factors Follow-Up Purpose Implementation 1.5 Benign Diseases of the Stomach 1.5.1 Gastroduodenal Ulcer Disease Etiology Appearance Risk Factors Symptoms Diagnosis Endoscopy (EGD) Radiology Further Diagnosis Complications Therapy Conservative Therapy Interventional Therapy Surgical Therapy 1.5.2 Guidelines 1.6 Malignant Diseases of the Stomach 1.6.1 Gastric Adenocarcinoma Definition Forms Epidemiology and Etiology Occurrence Risk Factors Tumor Spread Classification TNM 7 Classification (2010) UICC Stages According to the TNM Classification Symptoms Diagnosis Esophagogastroduodenoscopy/Endosonography Thoracic CT, Abdominal CT Diagnostic Laparoscopy PET-CT, MRI Abdomen, Bone Scintigraphy Therapy Indication Multimodal Therapy Principles Perioperative Chemotherapy Adjuvant Radiochemotherapy Additive/Palliative Therapy Principles Strategy Operative Therapy Principles Prognosis Prognostic Factors Follow-Up Goals Implementation 1.6.2 Gastrointestinal Stromal Tumours (GIST) 1.6.3 Guidelines 1.7 Diseases of the Duodenum 1.7.1 Diverticular Disease of the Duodenum Incidence Types Symptoms Therapy Complications 1.7.2 Duodenal Cancer Etiology and Tumor Manifestation Appearance Symptoms Diagnosis and Therapy Diagnosis Endoscopic Therapy Surgical Therapy Multimodal Therapy Palliative Therapy Prognosis 1.7.3 Guidelines References 2: Small Intestine and Appendix 2.1 Anatomy of the Small Intestine 2.1.1 Measured Values 2.1.2 Limits 2.1.3 Wall Structure of the Small Intestine 2.1.4 Circulation Arterial Blood Flow Venous Drainage Lymphatic Drainage Mesenteric Base 2.1.5 Innervation Parasympathetic Component Sympathetic Component 2.1.6 Small Intestine Functions Digestion and Nutrient Absorption Endocrinological Function Immunological Function 2.2 Diseases of the Small Intestine 2.2.1 Clinical Presentation General Inflammatory Bowel Disease Development Symptoms Complications Neoplastic Intestinal Diseases Symptoms GIST (Gastrointestinal Stromal Tumors)/Carcinoid Tumors 2.2.2 Imaging Radiological Imaging Conventional Abdominal Radiograph CT Examination with Contrast Medium Colon Contrast Enema CT Enterography/MRI Enterography Abdominal Sonography Endoscopic Imaging Colonoscopy/Esophagogastroduodenoscopy (EGD) Double Balloon Endoscopy Capsule Endoscopy 2.2.3 Crohn’s Disease Pathophysiology Diagnosis Differential Diagnosis (= Other Inflammatory Bowel Diseases) 2.2.4 Small Intestinal Neoplasms Epidemiology Diagnosis Histological Classification Adenomas Hamartomas Hemangiomas Gastrointestinal Stromal Tumors (GIST) Adenocarcinomas Lymphomas Small Intestine NET (Carcinoid Tumors) Metastatic Lesions 2.2.5 Other Diseases of the Small Intestine Diverticula and Meckel’s Diverticula Duodenum Diverticulum Jejunum and Ileum Diverticula Meckel’s Diverticulum Ulcerations and Fistulas Ulcerations Enterocutaneous Fistulas Small Bowel Obstruction/Ileus Etiology Classification of Obstruction/Ileus Clinical Presentation Complications Diagnosis Treatment 2.2.6 Treatment Strategies Drug Therapy Crohn’s Disease Malignant Lesions GIST/Small Bowel NET (Carcinoid) Surgical Treatment General Principles Segmental Small Bowel Resection + Anastomosis Laparoscopic Resection Bypass Procedures Treatment of CIBD (E.g. Crohn’s Disease) Indications for Surgical Treatment Strategy Treatment of Benign Lesions Treatment of Malignant Lesions 2.3 Vermiform Appendix 2.3.1 Anatomy of the Vermiform Appendix Normal Anatomy Localization Variations (According to Wakeley and Testut & Latarjet) Circulation and Lymphatic Drainage Histological Features 2.4 Diseases of the Appendix 2.4.1 Appendicitis Vermiformis Physiopathology Symptoms Initial Symptoms Progressive Symptoms (Due to Inflammation of the Surrounding Structures) Clinical Presentation: Biochemistry Clinical Presentation Biochemistry Imaging Ultrasound (US) Computer Tomography (CT) Diagnostic Laparoscopy Differential Diagnosis Operative Differential Diagnosis Non-Operative Differential Diagnosis Gynaecological Differential Diagnosis Surgical Treatment Modalities Treatment Strategy Early Surgical Appendectomy Antibiotic Treatment Laparoscopic Appendectomy Minimally Invasive (Laparoscopic) Appendectomy = Currently the Gold Standard Controversy with Normal Appearing Appendix at Laparoscopy Resection Technique Evidence-Based Approach Open Appendectomy McBurney Incision Median Laparotomy Drug Therapy Uncomplicated Appendicitis Severe Complications (Depicted by Imaging) Treatment Strategy 2.4.2 Malignant Diseases Mucocele of the Appendix Pathophysiology Epidemiology Clinical Presentation Diagnosis Tumor Marker (Preoperative) Sonography CT Abdomen Colonoscopy Treatment Retention Cysts Appendix Mucoceles Ruptured Mucocele (= Pseudomyxoma Peritonei/Mucinous Carcinomatosis) Forecast Prognostic Factors Course of the Disease Survival Carcinoid Tumors: Neuroendocrine Tumors of the Appendix Epidemiology Diagnosis Non-functional NET Functional NET Environment Diagnosis Treatment (According to Recommendations of the American National Cancer Institute and ENETS) Aftercare Noncarcinoid Tumors of the Appendix Classification According to World Health Organisation (WHO) (. Table 2.2) Clinical Presentation Treatment References 3: Colon 3.1 Anatomy and Physiology 3.1.1 Definition and Limits 3.1.2 Tasks 3.1.3 Location and Classification 3.1.4 Measured Values 3.1.5 Characteristic Features of the Colon 3.1.6 Blood Supply and Drainage Arteries Veins Lymphatic Drainage (. Fig. 3.1) 3.2 Benign Diseases of the Colon 3.2.1 Diverticulosis and Diverticulitis Definitions Colon Diverticulum Diverticular Disease Diverticulitis (= Pathological) Epidemiology Etiology/Pathogenesis Risk Factors Complications Symptoms Classifications Diagnosis Medical History (Medication, Tobacco Consumption) Clinical Examination Laboratory Tests Diagnostic Imaging Therapy Prophylaxis of Diverticulitis Primary Prophylaxis Secondary Prophylaxis Conservative Therapy Asymptomatic Diverticulosis Complicated Diverticulitis Surgical Therapy Surgery Indications Surgical Strategy 3.2.2 Colonic Polyps Definition Epidemiology Classification (. Table 3.4) Symptoms Diagnosis Therapy Endoscopic Therapy Guideline: Polypectomy Implementation Postpolypectomy Strategy Follow-up Surgical Therapy Follow-Up Care After Colonoscopic Ablation 3.2.3 Ulcerative Colitis Definition Epidemiology Etiology Etiopathogenesis Course Clinical Presentation Intestinal Manifestations Extraintestinal Manifestations (15–20%) Course Complications Diagnosis Anamnesis Complete Physical Examination Lab Imaging Endoscopy Differential Diagnosis Therapy Conservative-Medical Therapy Uncomplicated Ulcerative Colitis Proctitis Left-Sided Colitis Complicated/Severe Ulcerative Colitis Time-Adapted Approach Surgical Therapy Surgery Indications Standard Surgery: Restorative Proctocolectomy Follow-Up Alternative Procedure Preventive Care (Cancer Prophylaxis) 3.2.4 Chronic Constipation Definition Epidemiology Etiology Diagnosis Anamnesis Physical Examination Further Diagnosis Therapy Step-By-Step Therapy (. Fig. 3.2) Surgery 3.2.5 Guidelines 3.3 Colon Cancer and Hereditary CRC Syndromes 3.3.1 Colon Carcinoma Definition Epidemiology Etiology and Pathogenesis Risk Categories Protective Factors Pathogenesis Classification TNM Classification (2017) UICC Staging of Colorectal Cancer Histological Grading Symptoms Complications Diagnosis Standard Investigations Guideline-Based Preoperative Diagnostic of Tumor Staging Colorectal Cancer Screening (in the Asymptomatic Population) Guideline: Polypectomy Therapy Treatment Strategy Surgical Therapy Principles of Surgical Therapy Postoperative Complications Principles for Specific Situations Principles in Metastatic Colon Cancer Adjuvant Chemotherapy Indications Contraindications Standard Chemotherapy = FOLFOX (5-FU/Folinic Acid/Oxaliplatin) Palliative Chemotherapy Oncologic Follow-up Prognosis 3.3.2 HNPCC (Hereditary Non-polyposis Colorectal Cancer): Lynch Syndrome Definition Epidemiology Etiology Diagnosis Anamnesis Test for Mismatch Repair Defect Prevention Surgical Therapy 3.3.3 Other Hereditary CRC Syndromes Familial Adenomatous Polyposis (FAP) Definition Etiology Tumour Spectrum Prevention Therapy Follow-Up Hamartomatous Polyposis Syndromes Definition Prophylaxis Diagnosis and Therapy 3.3.4 Guidelines Reference Suggested Reading 4: Rectum 4.1 Anatomy and Physiology 4.1.1 Definition, Location and Structure Definition Location Limits 4.1.2 Anatomy and Embryology Topographic Anatomy Blood Supply and Drainage Innervation 4.1.3 Physiology Special Functions of the Rectum 4.2 Benign Diseases 4.2.1 Benign Neoplasms/Malformations Polyps/Adenomas (Chap. 3) Schwannomas, Leiomyomas, Angiomyomas Hirschsprung’s Disease Infiltrating Endometriosis 4.2.2 Rectal Prolapse Definition, Classification, Differential Diagnosis, Epidemiology Definition Classification Differential Diagnoses Epidemiology Etiology and Pathogenesis Symptoms and Diagnosis Symptoms Diagnosis Therapy Non-surgical Therapy Surgical Therapy Perineal and Transanal Procedures Abdominal Procedures 4.3 Malignant Diseases 4.3.1 Histological Tumour Entities 4.3.2 Rectal Cancer Definition Forms/Classification Epidemiology and Etiology Tumor Spread Classification Classification According to Mason (Clinical Staging) TNM Classification (2017) Derivation of UICC Stages from TNM Classification Symptoms Diagnosis Rectal Digital Examination Rigid Rectoscopy Colonoscopy Endorectal Ultrasound MRI Pelvis Thoracic CT, Abdominal CT PET-CT Therapy Indication Neoadjuvant Therapy Long-Term Radiochemotherapy (Preferred in Germany and USA) Short-Term Therapy (Preferred in the Netherlands, Poland and Scandinavia) Adjuvant Therapy Modalities Results Additive/Palliative Therapy Principles Strategy Operative Therapy Principles Local Limited Procedures Rectal Resection Abdominoperineal Rectal Extirpation Prognosis Prognostic Factors 5-Year Survival Rates Follow-up Targets Time Intervals Special Features 4.3.3 Guidelines Further Reading Suggested Reading 5: Anorectum 5.1 Anatomy and Physiology 5.1.1 Anatomy 5.1.2 Physiology 5.2 Benign Diseases 5.2.1 Hemorrhoidal Disease Definition Classification Epidemiology Etiology Symptoms Diagnosis Differential Diagnosis Therapy Basic Therapy Conservative and Interventional/Semioperative Therapy Sclerotherapy (Blond or Blanchard or Bensaude procedures) Infrared Coagulation Rubber Ring Ligation (According to Barron) Doppler-Guided Hemorrhoidal Artery Ligation (HAL) Recto-Anal Repair Surgical Therapy Milligan-Morgan Hemorrhoidectomy Ferguson Hemorrhoidectomy Subanodermal Resection (Parks Procedure) Stapler Hemorrhoidopexy (Longo Procedure) Therapy Strategy for Grade 4 Hemorrhoids Complications 5.2.2 Anal Vein Thrombosis Definition Epidemiology Etiology Triggering Factors Symptoms Diagnosis Differential Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.3 Anal Fissure Definition Acute Anal Fissure Chronic Anal Fissure Epidemiology Etiology Main Cause = Heavy Pressing Other Causes Symptoms Diagnosis Differential Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.4 Anorectal Abscess Definition Epidemiology Etiology Cryptoglandular Origin Rarer causes Symptoms Diagnosis Differential Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.5 Anorectal Fistulas Definition and Classification Definition Classification of Anorectal Fistulas (According to Course) Epidemiology Etiology Cryptoglandular Origin Rarer Forms of Fistula Symptoms Diagnosis Differential Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.6 Pilonidal Sinus Definition Epidemiology Etiology Risk Factors Pathophysiology Symptoms Asymptomatic Form Acute Abscessed Form Chronic Form Diagnosis Differential Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.7 Fecal Incontinence Definition Clinical Classification Score Classification Epidemiology Etiology Pathophysiology Risk Factors Symptoms Diagnosis Therapy Conservative Therapy Surgical Therapy Complications 5.2.8 Anorectal Voiding Dysfunction (Outlet Constipation) Definition Definition Classification Epidemiology (Of All Forms of Constipation) Etiology Symptoms Diagnosis Therapy Surgical Therapy Complications 5.3 Malignant Disease: Anal Carcinoma 5.3.1 Definition Anal Carcinoma Classification: TNM Classification Anal Margin Carcinoma 5.3.2 Epidemiology 5.3.3 Aetiology 5.3.4 Symptomatology 5.3.5 Diagnosis 5.3.6 Differential Diagnosis 5.3.7 Therapy Conservative Therapy Surgical Therapy Complications 5.4 Guidelines Suggested Reading 6: Endocrine Organs 6.1 Anatomy and Physiology of the Thyroid Gland 6.1.1 Embryology and Anatomy Macroscopy Microscopy Localization Blood Supply Development 6.1.2 Physiology Thyroid Hormones (Thyroxine, T4, and Triiodothyronine, T3) Control Loop (Negative Feedback) Calcitonin 6.2 Diseases of the Thyroid Gland 6.2.1 Epidemiology Goiter and Multinodular Goiter Hyperthyroidism (Thyroid Autonomy) Autoimmune Diseases Thyroid Cancer 6.2.2 General Methods of Investigation Clinical Examination Laboratory Thyroid Function Tests Basic Diagnosis (For Each Patient) Specific Diagnosis (For Further Clarification) Imaging Studies Ultrasound Computer Tomography (CT) Magnetic Resonance Imaging (MRI) Nuclear Medicine Diagnosis Fine Needle Aspiration Cytology (FNA) Principle Interpretation of the Cytological Findings Diagnostic Strategy 6.2.3 Basics of Surgical Therapy, Complications and Postoperative Care Preoperative Measures Basics of Surgical Therapy Minimally Invasive Surgical Techniques Cervical Lymphadenectomy (LAD) for Thyroid Cancer Surgical Anatomy and Classification Systems Pathophysiology Sentinel Node Biopsy Technique Selective LAD (“Berry Picking”) Compartment-Oriented LAD Postoperative Complications Bleeding Needing Revision Recurrent Laryngeal Nerve Lesion Parathyroid Hypofunction (= Hypoparathyroidism; . Fig. 6.6) Thyrotoxic Crisis Tracheomalacia Postoperative Care 6.2.4 Benign Thyroid Diseases Hypothyroidism Definition Symptoms Diagnosis Therapy Hyperthyroidism Definition Etiology Symptomatology (. Table 6.2) Toxic Nodules (= Autonomies) Definition Epidemiology Symptoms Diagnosis Therapy Immunothyreopathy: Graves’ Disease Definition Epidemiology Pathophysiology Symptoms Diagnosis Therapy Thyroiditis Acute Thyroiditis Pathogenesis Symptoms Diagnosis Therapy Subacute Thyroiditis (De Quervain) Pathogenesis Symptoms Diagnosis Therapy Autoimmune Thyroiditis Symptoms Diagnosis Therapy Special Forms of Thyroiditis Traumatic Thyroiditis Drug-Induced Thyroiditis Goiter and Nodular Goiter Definition Goiter Nodular Goiter Pathogenesis Diagnosis Clinical Examination Ultrasound Scintigraphy (7 Sect. 6.2.2) FNA Laboratory (Standard Levels, 7 Sect. 6.2.2, Laboratory Thyroid Function Tests) Therapy Medical Therapy and Prophylaxis Surgical Therapy 6.2.5 Malignant Thyroid Diseases Cancers of the Thyroid Gland Definition (. Table 6.13) Papillary Thyroid Cancer (PTC) Epidemiology Molecular Pathology BRAF Mutation: Approx. 50% of PTC Prognosis Therapy Principles Follicular Thyroid Cancer (FTC) Epidemiology Molecular Pathology Prognosis Therapy Principles Poorly Differentiated Thyroid Cancer Epidemiology Molecular Pathology Prognosis Therapy Principles Anaplastic Thyroid Cancer Epidemiology Molecular Pathology Prognosis Therapy Principles Medullary Thyroid Cancer (MTC) Epidemiology Molecular Pathology Prognosis Therapy Principles Familial Non-Medullary Thyroid Cancer (7 Sect. 6.3) Rare Thyroid Cancers Primary Malignant Lymphoma of the Thyroid Gland Primary Sarcomas of the Thyroid Gland Metastases in the Thyroid Gland 6.2.6 Workup of a Solitary or Dominant Thyroid Nodule Epidemiology Symptoms Diagnosis Medical History and Clinical Examination Laboratory Diagnosis (7 Sect. 6.2.2 Laboratory Thyroid Functuon Tests) Ultrasound Scintigraphy FNA (7 Sect. 6.2.2 Fine Needle Aspiration Cytology) (. Fig. 6.3) Therapy Indications for Surgical Therapy Indications for Conservative Therapy Operative Therapy Principles 6.2.7 Guidelines 6.3 Familial Malignant Syndromes of the Thyroid Gland 6.3.1 Introduction (. Table 6.14) Genetics 6.3.2 Hereditary Medullary Thyroid Carcinoma Medullary Thyroid Carcinoma (MTC) Clinical Presentation Diagnosis Treatment Multiple Endocrine Neoplasia 2A (MEN 2A) Epidemiology Genetics Clinical Presentation Diagnosis Treatment (. Table 6.15) Multiple Endocrine Neoplasia 2B (MEN 2B) Epidemiology Genetics Clinical Presentation Diagnosis Therapy (. Table 6.15) Familial Medullary Thyroid Carcinoma (FMTC) Epidemiology Genetics Clinical Presentation Diagnosis Treatment 6.3.3 Familial Papillary Thyroid Carcinoma (FPTC) Clinical Presentation Diagnosis Screening Recommendations Treatment 6.3.4 Rare Genetic Syndromes Associated with Thyroid Cancer Familial Adenomatous Polyposis (FAP) Epidemiology Genetics Clinical Presentation Diagnosis Treatment Gardner Syndrome Definition and Epidemiology Genetics Clinical Presentation Diagnosis Treatment Cowden Syndrome Epidemiology Genetics Clinical Manifestations Diagnosis Management Treatment Carney Complex I Epidemiology Genetics Presentation Diagnosis Treatment 6.3.5 Guidelines 6.4 Anatomy and Physiology of the Parathyroid Gland 6.4.1 Anatomy Localization Blood Supply 6.4.2 Physiology (. Fig. 6.4) Parathormone (PTH) Calcium (Ca++) Control Loop (Negative Feedback) 6.5 Diseases of the Parathyroid Gland 6.5.1 Benign Parathyroid Diseases Primary Hyperparathyroidism (pHPT) Definition Forms Sporadic pHPT Hereditary pHPT (7 Sect. 6.3) Epidemiology Symptoms Diagnosis Laboratory Diagnosis (. Fig. 6.5) Diagnostic Imaging Genetic Workup Differential Diagnosis (. Fig. 6.6) Secondary (sHPT), Tertiary HPT (tHPT) (See Below) Familial Hypocalciuric Hypercalcemia (FHH) Milk-Alkali Syndrome Lithium Therapy Malignancy-Associated Hypercalcemia Granulomatous Disease Endocrinopathies Drugs Immobilization, Bed Rest Therapy Indications for Medical Therapy Indications for Surgical Therapy Operative Therapy Principles Complications (Section “Postoperative Complications”) Reoperation Secondary Hyperparathyroidism (sHPT) Definition Etiology (. Table 6.24) Renal sHPT Extrarenal sHPT (= Differential Diagnosis) (. Table 6.23) Symptoms Diagnosis (. Fig. 6.5) Therapy Conservative/Medical = Primary Therapy of sHPT Surgical Therapy Postoperative Follow-Up: Like pHPT (See Above “pHPT”) Tertiary Hyperparathyroidism (tHPT) Definition Etiology Therapy Hypoparathyroidism Epidemiology Symptoms Diagnosis Etiology Therapy 6.5.2 Parathyroid Cancer Epidemiology Symptoms Diagnosis Therapy 6.5.3 Guidelines 6.6 Anatomy and Physiology of the Adrenal Gland 6.6.1 Embryology 6.6.2 Anatomy Topographic Anatomy Location Blood Supply Innervation Histological Anatomy Adrenal Cortex Adrenal Medulla Positional Relationships 6.6.3 Physiology Steroid Hormones Glucocorticoids Effects of Glucocorticoids Regulation (. Fig. 6.8) Mineralocorticoids Effects of Mineralocorticoids Regulation (. Fig. 6.9) Adrenal Sexual Steroids Effects of Adrenal Sexual Steroids Regulation Catecholamines Regulation Effects of Catecholamines 6.7 Diseases of the Adrenal gland 6.7.1 Primary Hyperaldosteronism (Conn Syndrome) Definition Etiopathogenesis Etiologies Pathogenesis (7 Sect. 6.6.3) Clinical Presentation Diagnosis (See Algorithm . Fig. 6.10) Laboratory Adrenal Function Tests Etiological Diagnosis Diagnostic Imaging Selective Venous Sampling Therapy Medical (Drug) Therapy Surgical Therapy Results 6.7.2 Cortisol-Producing Adrenal Adenoma Definition Cushing’s Syndrome Cushing’s Disease ACTH Syndrome Epidemiology and Etiology Clinical Signs Diagnosis Laboratory Adrenal Function Tests Overnight Cortisol Suppression Test Free Cortisol 24 h Urine Test 48-h Low-Dose Dexamethasone Test Etiological Diagnosis ACTH in Plasma Therapy Surgical Therapy Cushing’s Disease Ectopic ACTH Secretion Syndrome Cushing’s Syndrome in Adrenal Tumor (Adenoma or Carcinoma) Medical (Drug) Therapy 6.7.3 Pheochromocytoma Definition Epidemiology Clinical Signs Arterial Hypertension Other Symptoms Diagnosis Laboratory Function Tests Etiological Diagnosis = Localisation Diagnosis CT Scan MRI MIBG Scintigraphy Therapy Preoperative Preparation Background Principle Surgical Therapy Strategy Principles of Surgical Therapy (7 Sect. 6.7.7) Postoperative Monitoring/Follow-Up Chemotherapy Radiotherapy Palliative Therapy 6.7.4 Adrenocortical Carcinoma Definition Epidemiology and Prognosis Epidemiology Prognosis Clinical Signs Unclear Abdominal Complaints Symptoms of Overproduction of Adrenocortical Hormones Diagnosis Biochemical Screening Imaging Therapy Surgical Therapy Strategy Postoperative Follow-Up Chemotherapy Radiotherapy 6.7.5 Adrenal Incidentaloma Definition Epidemiology Clinical Evidence Functional Incidentalomas Non-functional Incidentalomas Evaluation Algorithm Therapy Indications for Surgical Therapy Strategy 6.7.6 Adrenal Metastases Epidemiology Clinical Signs Diagnosis Therapy Surgical Therapy 6.7.7 Principles of Adrenal Surgery General (. Fig. 6.13) Decisive Factors for the Choice of a Procedure General Rule Open Adrenalectomy Indications Technique Laparoscopic Adrenalectomy Advantages (Compared to Open Access) Good Candidates for Laparoscopic Adrenalectomy Retroperitoneoscopic Adrenalectomy Indications Advantages Contraindications 6.7.8 Guidelines References Further Reading 7: Bariatric and Metabolic Surgery 7.1 Epidemiology 7.1.1 Incidence 7.1.2 Health Economic Consequences 7.2 Pathophysiology and Principle of Action of Bariatric Surgery 7.2.1 Pathophysiology 7.2.2 Working Principle of Bariatric Surgery Restrictive Methods Hypoabsorptive Methods Combined Methods 7.3 Clinical Evidence 7.3.1 Bariatric Surgery: Laparoscopic Versus Open 7.3.2 Bariatric Surgery: Prospective Controlled Studies 7.3.3 Metabolic Consequences of Bariatric Surgery 7.3.4 Mortality: Bariatric Surgery Versus Drug Therapies 7.4 Specific Current Bariatric Interventions 7.4.1 Roux-Y Gastric Bypass “Gastric Bypass” 7.4.2 Banded Gastric Bypass 7.4.3 Laparoscopic Adjustable Gastric Banding (LAGB) 7.4.4 Biliopancreatic Diversion (BPD) 7.4.5 Biliopancreatic Diversion with Duodenal Switch (BPD/ DS) 7.4.6 Gastric Sleeve Resection 7.5 Complications 7.5.1 Mortality Causes of Mortality Risk Factors 7.5.2 Gastrointestinal Complications Nausea and Vomiting Dumping Syndrome Deficiency Symptoms Other Gastrointestinal Complications 7.5.3 Other Complications Complications in the SOS Study (Sjöström 2013) 7.6 Historical Interventions and Interventions in the Context of Studies 7.6.1 Historical Interventions Jaw Wiring Adjustable Gastric Banding (Vertical Banded Gastroplasty) Jejunoileal Bypass (Intestinal Bypass) Stomach Partitioning 7.6.2 Interventions in the Context of Studies Laparoscopic Gastric Plication “Gastric Plication” Endoscopic Sleeve Gastroplasty “Gastric Plication” Mini Gastric Bypass Ileal Transposition with/Without Sleeve Gastrectomy Laparoscopic “Jejunal Sleeve” (On Gastric Bypass/Sleeve) Laparoscopic Single Anastomosis Duodenal Switch (SADI-S) Myoelectric Gastric Stimulation 7.7 Metabolic Surgery 7.7.1 Definition 7.7.2 Scientific Basis 7.8 S3 Guidelines (February 2018) 7.8.1 Quality Assurance 7.8.2 Diagnosis and Evaluation 7.8.3 Indication 7.8.4 Choice of Procedure 7.8.5 Technical Aspects and Complications 7.8.6 Aftercare 7.8.7 Guidelines References Suggested Reading 8: Liver, Gallbladder and Bile Ducts 8.1 Anatomy and Physiology of the Liver 8.1.1 Definitions 8.1.2 Macroscopic and Microscopic Anatomy Macroscopic Anatomy Ligaments and Ligamentous Attachments Functional Subdivision Microscopic Anatomy 8.1.3 Tasks of the Liver and Functional Liver Volume Tasks of the Liver Blood Formation Site (Embryonic Period) Protein Biosynthesis and Degradation Cleavage of Carbohydrates and Glycogen Storage Central Organ of Lipometabolism Special Metabolic Services Detoxification Function (Through Biotransformation) Central Organ of the Trace Element Metabolism Immunological Function Functional Liver Volume After Resection Functional Liver Volume After Resection (FLR) FLR Targets Measurement of FLR 8.1.4 Location Position Projection 8.1.5 Measured Values Weight Linear Readings 8.1.6 Blood Supply and Drainage Blood Supply and Drainage of the Liver Arterial Inflow = Hepatic Artery Portal Venous Inflow = portal vein Venous Outflow 8.1.7 Terminology of Liver Resections (. Fig. 8.1) Anatomical (= Typical) Liver Resections Atypical Liver Resections 8.2 Diseases of the Liver 8.2.1 Benign Diseases Hepatocellular Adenomas Definition and Subtypes Definition Subtypes Epidemiology and Risk Factors Epidemiology Risk Factors Symptoms and Complications Diagnosis Surgery Indication Focal Nodular Hyperplasia (FNH) Definition Epidemiology Diagnosis Complications Therapy Conservative Approach: Generally Surgical Therapy Hemangiomas Definition Epidemiology Clinical Presentation and Complications Clinical Presentation Complications Diagnosis Therapy Conservative Therapy Surgical Therapy Echinococcosis Definition Clinical Presentation E. granulosus (Cysticus, Unilocularis), Dog Tapeworm E. multilocularis (alveolaris), Fox Tapeworm Diagnosis Therapy Surgical Therapy 8.2.2 Malignant Diseases of the Liver Primary Tumors Hepatocellular Carcinoma (HCC) Epidemiology and Risk Factors Early Detection Special Forms Clinical presentation and Classification Diagnosis Surgical Therapy Intrahepatic Cholangiocarcinoma: CCC Definition Epidemiology Symptoms and Classification Diagnosis Therapy CCC of the Common Hepatic Duct Bifurcation: Klatskin Tumors Definition Epidemiology Symptoms and Classification Prognosis Therapy Liver Metastases Indications Therapy 8.2.3 Technique of Liver Resection Planning of the Resection Technical Conditions Parenchyma Conditions Caution Strategy of Resection Resection Type Minor Resection (<3 Segments) Major Resection Technology Possible Complications 8.3 Liver Transplantation 8.3.1 General and Legal Basis (National) Legal Basis Definition Indication and Listing Indication for Liver Transplantation Listing Organ Allocation Eurotransplant Principles of Organ Allocation 8.3.2 Evaluation and Follow-Up of Liver Function Clinical Follow-Up Laboratory Parameters of Liver Synthesis and Excretion Hepatocellular Integrity Biliary Integrity Synthesis Performance of the Liver Excretory Capacity of the Liver Scoring Systems for Liver Function and Prognosis Child-Pugh Score (. Table 8.1) MELD Score 8.3.3 Indications for Liver Transplantation: Relevant Underlying Diseases in Adults Chronic Liver Disease Underlying Disease for Liver Cirrhosis Cholestatic Liver Disease Chronic Drug Toxicity Metabolic Diseases/Genetic Diseases Other Diseases Acute Liver Disease Malignant Diseases of the Liver Hepatocellular Carcinoma (HCC) Cholangiocarcinoma (CCC) Epithelioid Hemangioendothelioma 8.3.4 Contraindications for Liver Transplantation Lack of Patient Adherence/Psychosocial Problems High Age Cardiovascular and Pulmonary Concomitant Diseases Infections Extrahepatic Metastases 8.3.5 Surgical Principles Patient Positioning Laparotomy Recipient Hepatectomy Machine Perfusion of the liver Implantation Vena Cava Anastomosis Portal Vein Anastomosis Reperfusion Portal vein Hepatic artery Bile Duct Postoperative Phase 8.4 Anatomy and Physiology of the Gallbladder and Bile Ducts 8.4.1 Gallbladder (Vesica Biliaris) 8.4.2 Bile Ducts 8.4.3 Blood Supply and Drainage of the Gallbladder and Bile Ducts Blood Supply of the Extrahepatic Bile Ducts + Gallbladder Blood Supply of the Intrahepatic Bile Ducts 8.5 Diseases of the Gallbladder and Bile Ducts 8.5.1 Benign Diseases of the Gallbladder Cholecystolithiasis Definition Epidemiology Classification Symptoms Complications Diagnosis Clinical Presentation Lab Chemistry Imaging Non-Invasive Procedures Imaging Invasive Procedures Further Etiological Clarification Therapy Conservative Therapy Surgical Therapy Gallbladder Polyps Definition Epidemiology Clinical Presentation Diagnosis Therapy Surgical Therapy Conservative Therapy Acute Cholecystitis Definition Pathophysiology Course Other Risk Factors Symptoms Symptoms Complications of Acute Cholecystitis Diagnosis Clinical Presentation Lab Sonography Therapy Indication OP Procedure 8.5.2 Benign Diseases of the Bile Ducts Choledocholithiasis Definition Epidemiology Clinical Presentation Therapy Indication Choledochal Cysts Definition Epidemiology Pathogenesis Clinical Presentation Diagnosis Therapy 8.5.3 Gallbladder Carcinoma Epidemiology Symptoms Diagnosis Sonography CT Abdomen and Thorax Alternative MRI with Magnetic Resonance Cholangiopancreatography (MRCP) TNM Classification and Staging (UICC 2010) TNM Classification Therapy Surgical Therapy OP Indication/Strategy Adjuvant Therapy References Further Reading Suggested reading 9: Pancreas 9.1 Anatomy and Physiology 9.1.1 Definition, Location and Structure 9.1.2 Anatomy and Embryology Embryology (. Fig. 9.1) Anatomy 9.1.3 Physiology Exocrine Function Endocrine Function Control of the Functions 9.2 Benign Diseases 9.2.1 Acute Pancreatitis Definition Forms Acute Edematous Pancreatitis Acute Necrotizing Pancreatitis Epidemiology Incidence Etiology Symptoms Diagnosis Laboratory Diagnosis Diagnostic Imaging Risk Assessment (. Table 9.1) Differential Diagnosis Therapy Etiology-Oriented Therapy Conservative Therapy Step-Up Approach Operative Therapy Principles Prognosis 9.2.2 Chronic Pancreatitis Definition Forms Complications Epidemiology Etiology Alcohol Abuse (75–90%) Nicotine Abuse Hyperparathyroidism (with Ca2+ Elevation) Hereditary Autoimmunological (IgG-4 and Lymphoplasmocytic Infiltrates) Symptoms Abdominal Pain Symptoms Associated with Loss of Function Diagnosis Genetic Examination Laboratory Diagnosis (. Table 9.2) Diagnostic Imaging Sonography Endosonography CT/MRI/Magnetic Resonance Cholangiopancreaticography (MRCP) ERCP Differential Diagnosis Therapy Treatment Strategy Indications for Conservative Therapy Indications for Interventional or Surgical Therapy Operative Therapy: Principles Division: Resecting/Draining Procedures Surgical Strategy Monitoring and Follow-Up 9.2.3 Guidelines 9.3 Malignant Diseases 9.3.1 Pancreatic Carcinoma Definition Epidemiology Etiology Underlying Genetic Defects Hereditary Syndromes Forms Symptoms Diagnosis (. Fig. 9.6) Patient History + Clinical Examination Imaging Techniques Therapy Curative Therapy Preoperative Therapy Operation Pathology Postoperative Complications Postoperative Treatment: Adjuvant Chemotherapy Palliative Therapy Indications Therapy Regime 9.3.2 Guidelines 9.4 Cystic Neoplasms 9.4.1 Intraductal Papillary Mucinous Neoplasia (IPMN) Definition Epidemiology (. Table 9.6) Etiology Symptoms Diagnosis CT or MRI Imaging Signs Therapy (. Fig. 9.10) Surgical Therapy of MD-IPMN Indication for Surgery Aim of the Operation Principle Postoperative Management After Pancreatectomy Surgical Therapy of BD (“Branch-Duct”)-IPMN Postoperative Follow-Up Conservative Therapy of MD-IPMN (5–9 mm Main Duct) and BD-IPMN 9.4.2 Serous Cystic Neoplasms (SCN) Definition Epidemiology (. Table 9.6) Symptoms Diagnosis Therapy Surgical Therapy Conservative Therapy + Monitoring 9.4.3 Mucinous Cystic Neoplasia (MCN) Definition Epidemiology (. Table 9.6) Symptoms Diagnosis Therapy 9.4.4 Solid Pseudopapillary Neoplasia (SPN) Definition Epidemiology (. Table 9.6) Symptoms Diagnosis Therapy Always Operative Principles 9.4.5 Guidelines 9.5 Endocrine Neoplasms 9.5.1 Definition 9.5.2 Epidemiology 9.5.3 Symptoms Insulinoma Gastrinoma (Zollinger-Ellison Syndrome) VIPom Glucagonom Somatostatinoma Pancreatic Carcinoid Syndrome Non-Functional NET (95%) 9.5.4 Diagnosis Laboratory Diagnosis Chromogranin A Gastrin Fast Test Insulin, Plasma Glucose 5-Hydroxyindoleacetic Acid Imaging Techniques Contrast Enhanced Ultrasound Endosonography Multidetector CT 9.5.5 Therapy Benign Solitary NET with Local Resection Option (>2 cm) NET Without Local Resection Option Local Recurrences or Metastases of NET Diffuse Metastasized NET 9.5.6 Guidelines References 10: Kidney Transplantation 10.1 Introduction 10.1.1 Legal Framework 10.1.2 Structure in Germany German Foundation for Organ Transplantation Eurotransplant Transplant Centers 10.2 Indication for Transplantation and Preparation of the Recipient 10.2.1 Indication for Transplantation Indication = ESRD [End-Stage Renal Disease] Contraindications Causes of End-Stage Renal Disease 10.2.2 Recipient Preparation Detailed Information—Medical Aspects Medical Evaluation Diagnostic Procedure Detailed Anamnesis and Clinical Examination Laboratory Tests Apparative Examination Screening Evaluation by Specialist Vaccinations 10.2.3 Registration in the Waiting List Indication/Registration Urgency Status 10.3 Deceased Organ Donation 10.3.1 Organ Donation and Donor Selection Organ Donation Donor Selection Ischemia Times of Organs 10.3.2 Organ Allocation Allocation Programs 10.3.3 Organ Retrieval Principle 10.4 Living Kidney Donation 10.4.1 Prerequisites 10.4.2 Legal Limits in Germany 10.4.3 Advantages of Living Kidney Donation 10.4.4 Donor Evaluation [Preparation and Diagnosis] Initial Interview with the Potential Donor Detailed Medical Examination (Often Inpatient) Presentation to an Ethics Committee 10.4.5 Donor Operation OP Procedure Open Surgery Laparoscopic/Retroperitoneoscopic 10.4.6 Risks and Complications Mortality Morbidity Long-Term Risks 10.4.7 Donor Aftercare 10.5 Kidney Transplantation 10.5.1 Back-Table Preparation of the Kidney 10.5.2 Surgical Technique of Transplantation Implantation Site Immunosuppression 10.5.3 En Bloc Renal Transplantation Principle Advantages Disadvantages 10.5.4 Surgical Complications Vascular System (Incidence <5%) Postoperative Bleeding/Haematoma Arterial Thrombosis Graft Vein Thrombosis Renal Artery Stenosis Urological Complications (Incidence 2–10%) Urinary Leakage Ureteral Stenosis Ureteral Necrosis Lymphatic Complications (Incidence 2–18%) Lymphocele 10.6 Postoperative Treatment 10.6.1 Inpatient Stay Content Delayed Graft Function (DGF)/Acute Tubular Necrosis (ATN) 10.6.2 Immunosuppression Immunosuppressive Therapy Standard Triple Therapy Immunological Risk Factors Immunosuppressive Agents ABO-Incompatible Transplantation (Living Donation) 10.6.3 Organ Rejection Hyperacute Rejection Acute Rejection Chronic Rejection 10.6.4 Infections Bacterial Infections Opportunistic Infections 10.6.5 Aftercare 10.7 Results 11: Spleen 11.1 Spleen: Generalities 11.1.1 Embryology and Developmental Disorders Embryology Developmental Disabilities 11.1.2 Anatomy Structure Definition (. Fig. 11.1) Form Variations Measurements Measurements for Adults Location Vessels and Innervation Vessels Innervation 11.1.3 Physiology Filter Function Filter/Degradation Organ of the Altered Erythrocytes Storage/Degradation Organ of Platelets (and Clotting Products) Lymphatic Defense Organ 11.2 Spleen Diseases 11.2.1 Benign Haematological Diseases Idiopathic Thrombocytopenic Purpura (ITP) Definition Mechanism Epidemiology Clinical Examination Diagnosis Therapy Strategy Splenectomy Hereditary Spherocytosis Definition Mechanism Clinical Examination Diagnosis Therapy Hemolytic Anemia Due to Erythrocyte Enzyme Defect Definition Clinical Examination Therapy Haemoglobinopathies Definition Clinical Examination Therapy 11.2.2 Other Benign Diseases Splenic Cysts Classification Clinical Examination Epidemiology Therapy Splenic Abscess Risk Factors Clinical Examination Diagnosis Therapy 11.2.3 Malignant Diseases Lymphomas Leukemia Non-hematological Malignant Tumors 11.2.4 Spleen Trauma Epidemiology Pathophysiology Diagnosis Anamnesis Clinical Examination Ultrasound Examination Therapy 11.2.5 Post-splenectomy Morbidity Asplenia: Pathophysiology Prophylactic Therapy in Asplenia Patients References Further Reading 12: Peritoneum 12.1 Anatomy and Physiology of the Peritoneum 12.1.1 General Anatomy Definition Structure (Histology) Division 12.1.2 Physiology (Tasks) of the Peritoneum Organ Mobility Resorption Immunological Tasks (= Defence) 12.2 Benign Diseases of the Peritoneum 12.2.1 Peritonitis Definition Etiology Primary Peritonitis (Without Previous Abdominal Disease) Secondary Peritonitis Spontaneous Bacterial Peritonitis (e.g. in Ascites, Liver Cirrhosis) Special Form: Peritonitis After CAPD Catheter Insertion Classification Symptoms Diagnosis Therapy Surgical Therapy Conservative Therapy 12.2.2 Peritoneal Adhesions Epidemiology Clinical Presentation Diagnostic Imaging Therapy 12.3 Pseudomyxoma Peritonei 12.3.1 Definition 12.3.2 Classification 12.3.3 Aetiology 12.3.4 Clinical Presentation 12.3.5 Therapy 12.3.6 Prognosis 12.4 Malignant Diseases of the Peritoneum 12.4.1 Mesothelioma Definition Epidemiology Clinical Presentation Prognosis Therapy 12.4.2 Peritoneal Carcinomatosis Epidemiology Clinical Presentation Diagnosis Imaging Techniques Staging Laparoscopy Therapy Systemic Chemotherapy 12.5 Cytoreductive Surgery (CRS) and HIPEC 12.5.1 Curative CRS and HIPEC Theoretical Approach Concept and Goals Indication Risk-Benefit Analysis 12.5.2 Prophylactic/Adjuvant CRS and HIPEC Indications Evidence Learning Curve 12.5.3 Palliative Therapeutic Concepts for Ascites 12.5.4 Complications Most Common Complications Strategies to Minimize Complications 12.5.5 Results 12.5.6 PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) 12.5.7 Guidelines References Suggested Reading 13: Hernia 13.1 Anatomy and Classification 13.1.1 Hernia Anatomy 13.1.2 Epidemiology Hernia Incidence Hernia Distribution 13.1.3 Pathogenesis and Classification Pathogenesis Hernia Classification 13.1.4 Hernia-Specific Complications Intestinal Incarceration Hernia Mains Clamping 13.2 General Diagnosis and Therapy Principles 13.2.1 Diagnosis Physical Examination Sonography Further Investigations 13.2.2 Therapy Principles Procedure for Surgical Therapy 13.3 Incisional Hernia 13.3.1 Definition 13.3.2 Incidence 13.3.3 Aetiology 13.3.4 Clinical Presentation 13.3.5 Diagnosis Clinical Examination Sonography CT or MRI 13.3.6 Surgical Therapy Open Procedures Suture Procedure Sublay Technique Abdominal Wall Replacement Laparoscopic Procedures Special Procedures Component Separation According to Ramirez 13.3.7 Guidelines 13.4 Inguinal and Femoral Hernia 13.4.1 Anatomy, Definition and Classification Anatomy Definition Division 13.4.2 Epidemiology Inguinal Hernia Femoral Hernia 13.4.3 Pathophysiology 13.4.4 Clinical Presentation Asymptomatic Small Inguinal Hernia Symptomatic Inguinal Hernia Complications Femoral Hernia 13.4.5 Diagnostic Procedures Palpation of the Inguinal Canal Sonography CT/MRI Examination 13.4.6 Therapeutic Principles Evidence-Based Strategy (. Fig. 13.3) EHS (European Hernia Society) Recommendation Principles Complications Intraoperative EHS Classification (2007) Surgical Technology Inguinal Hernia Operative Procedure Shouldice Herniotomy Aftercare 13.4.7 Guidelines 13.5 Umbilical and Epigastric Hernia 13.5.1 Umbilical Hernia Definition Division 13.5.2 Epigastric Hernia Definition 13.5.3 Clinical presentation 13.5.4 Diagnosis 13.5.5 Therapy 13.5.6 Guideline 13.5.7 Differential Diagnosis: Rectus Diastasis Definition Etiology and Pathogenesis Clinical Presentation Therapy 13.6 Parastomal Hernia 13.6.1 Definition 13.6.2 Epidemiology 13.6.3 Risk Factors and Prevention Risk Factors Prevention 13.6.4 Clinical Presentation 13.6.5 Relevant Complications 13.6.6 Therapy Open Procedures Minimally Invasive Procedures 13.6.7 Guidelines 13.7 Other Rare Hernias 13.7.1 Spieghel’s Hernia (Hernia Lineae Semilunaris) 13.7.2 Hernia Obturatoria 13.7.3 Hernia Ischiadica 13.7.4 Hernia Perinealis 13.7.5 Lumbar Hernia References Further Reading 14: Gastrointestinal Stromal Tumors and Sarcomas 14.1 Gastrointestinal Stromal Tumours (GIST) 14.1.1 Definition 14.1.2 Epidemiology and Tumour Localisation Epidemiology Localization Tumor Biology Risk Factors 14.1.3 Clinical Presentation Manifestation Symptoms Prognosis at Diagnosis 14.1.4 Pathology Conventional Histology Immune Phenotype Mutation Detection 14.1.5 Diagnosis Diagnostic Imaging Tissue Biopsy 14.1.6 Therapy Surgical Therapy Indication General Principles GIST of the Stomach Adjuvant Treatment Antibodies (Ab) Against the Tyrosine Kinase Receptor Second-Line Therapy Neoadjuvant Treatment Goals Indications/Target Organs Multimodal Therapy Results of Neoadjuvant Therapy Assessment of the Therapeutic Success in Imaging Computer Tomography (CT scan) Positron Emission Tomography (PET) 14.1.7 Guidelines 14.2 Soft Tissue Tumours of the Extremities 14.2.1 General: Classification Epidemiology General Information STS Body-Distribution Pattern Rare Hereditary Risk Factors Acquired Risk Factors 14.2.2 Clinical Presentation Anamnesis Investigation 14.2.3 Diagnosis Local Diagnosis Ultrasound (Unclear Swelling of the Extremity) Native X-Ray Imaging in 2 Planes Magnetic Resonance Imaging (MRI): Gold Standard Fluorodeoxyglucose (FDG)-PET Diagnosis of Local and General Spread Pathophysiology Diagnosis Biopsy General Excisional Biopsy Open Incisional Biopsy Punch Biopsy 14.2.4 Classification Histological Classification Most Common Entities Staging and Grading Staging Grading UICC Stages According to the TNM Classification 14.2.5 Prognosis Main Prognostic Determinants for Non-Metastatic Tumours 5-Year Survival for Patients with STS of the Extremities 14.2.6 Therapeutic Principles Sarcoma Centre: Tumour Board—Interdisciplinary, Multimodal Therapy Surgery Oncosurgical Resective Surgery Wide Excision Compartment Resection Limb Amputation Reconstructive Surgery Surface Restoration Functional Restoration Tumor Recurrence Surgery Tumor Metastases Surgery Radiotherapy Principle Application Neoadjuvant Radiotherapy Intraoperative Radiotherapy Chemotherapy Hyperthermia/Isolated Limb Perfusion Tumor Follow-up Local Tumor Follow-up Systemic Tumor Follow-up 14.2.7 Guidelines 14.3 Retroperitoneal Sarcomas 14.3.1 Epidemiology and Prognosis Epidemiology Prognosis and Prognostic Factors 14.3.2 Pathology 14.3.3 Classification AJCC/UICC TNM Classification UICC Stages According to the TNM Classification 14.3.4 Molecular Genetics 14.3.5 Clinical Presentation Early Symptoms Clinical Symptoms (If Present) 14.3.6 Diagnosis Medical History and Clinical Examination Radiology Multiphase Spiral CT scan MRI PET/PET-CT Renal Scintigraphy Biopsy NCCN Guidelines 14.3.7 Therapy Surgical Therapy En Bloc Organ Resection Principle En Bloc Resection Morbidity and Mortality Independent Predictive Factors Associated with a Lower Locoregional Tumor Recurrence Rate Radiotherapy Preoperative Radiotherapy (PrR) Main Objectives of the PrR Theoretical Advantages of PrR (Nussbaum et al. 2014) Intraoperative Radiotherapy (IORT) Principle Limits of the IORT Postoperative Radiotherapy (PostR) Chemotherapy Preoperative Chemotherapy Adjuvant Chemotherapy 14.3.8 Management of Recurrences Incidence Treatment of the Recurrence 14.3.9 Follow up Evidence Strategy 14.3.10 Guidelines References 15: Perioperative Medicine 15.1 Preoperative Phase 15.1.1 Risk Stratification Identification of Patient-Related Risks Systemic Diseases with High Postoperative Risk Perioperative Risk (. Table 15.2) Intubation Conditions 15.1.2 Laboratory and Blood Products Blood Management Laboratory Diagnosis 15.1.3 Additional Investigations ECG Chest X-Ray Pulmonary Function Diagnosis 15.1.4 Perioperative Anticoagulation Coronary Artery Disease and Stent Implantation Perioperative Thrombosis Prophylaxis New Oral Anticoagulants (NOACs/DOACs) 15.1.5 Medication Management Continue Convert Discontinue Endocarditis Prophylaxis 15.1.6 Information from the Anaesthetist’s Point of View Legal Situation (Germany) Prerequisite Requirement Elements of Consent Outpatient Interventions Living Will or Health Care Proxy 15.2 Intraoperative Phase 15.2.1 Intraoperative Monitoring According to AAGBI and BDA Guidelines 15.2.2 Volume Management 15.2.3 Hemodynamics Pathophysiology Risk Factors for Hypotension Principles/Goals 15.2.4 Heat Retention 15.2.5 Perioperative Antibiotic Therapy Incidence of SSI (“Surgical Site Infection”) Risk Factors Pathogen Spectrum Prevention Perioperative Antibiotic Prophylaxis (PAP) 15.3 Postoperative Phase 15.3.1 Analgesia Pathophysiology Evidence-Based Analgesia Pain Measurement Principles 15.3.2 Postoperative Nausea and Vomiting (PONV) Forecasting Systems Prophylaxis Therapy 15.3.3 Delirium/Postoperative Cognitive Deficit (POCD) Epidemiology Division Preoperative Evaluation of Risk Factors Prevention Early Screening Therapy 15.3.4 Recovery Room (PACU) 15.3.5 Intensive Care Unit (ICU)/Intermediate Care (IMC) 15.4 Fast Track Surgery 15.4.1 Definition 15.4.2 Preoperative Management 15.4.3 Intraoperative Management 15.4.4 Postoperative Management Analgesia Early Mobilization Optimized Diet 15.4.5 Guidelines Reference 16: Emergency Surgery 16.1 Polytrauma: Abdominal Trauma 16.1.1 Anatomy of the Abdomen External Divisions Anterior Abdominal Wall Lateral Abdominal Wall (= Flank) Quadrant/Sector Breakdown Internal Divisions Abdominal Cavity Pelvis 16.1.2 Injury Mechanisms (Aetiology and Pathophysiology) Blunt Abdominal Trauma Deceleration Trauma Crush Injury Compression Injury Penetrating Abdominal Trauma Stab Wound Gunshot Wound Impalement Injury (Due to Accidents) 16.1.3 Management and Diagnosis Primary Management Anamnesis Clinical Presentation Laboratory Tests Diagnostic Imaging X-ray Ultrasound Examination Computer Tomography 16.1.4 Therapeutic Procedure Conservative Therapy Blunt Abdominal Trauma Penetrating Abdominal Trauma Surgical Therapy Circulatory Instability Circulatory Stability Major Visceral Trauma/Complex Surgery 16.1.5 Guidelines 16.2 Ileus/Obstruction 16.2.1 Definition—Classification Definition Classification 16.2.2 Epidemiology 16.2.3 Pathophysiology “Circulus Vitiosus” of Ileus Intestinal Distention 16.2.4 Diagnosis Medical History and Symptoms Clinical Examination: Status Survey Lab Quantity/Quality of Gastrointestinal Contents Discharged Imaging Ultrasound Conventional Abdominal Radiograph Contrast-Enhanced (Gastrographin) Conventional X-Ray Computer Tomography (CT scan) 16.2.5 Mechanical Ileus (Mechanical Obstruction) Etiology and Pathogenesis Etiology (. Table 16.1) Pathogenesis Specific Symptoms High Small Bowel Ileus Low Small Bowel Ileus Large Bowel Obstruction Complications 16.2.6 Paralytic Ileus/Functional Obstruction Etiology and Pathogenesis Etiology (. Table 16.2) Pathogenesis Specific Symptoms 16.2.7 Therapy Conservative Therapy General Measures Antibiotic Therapy Drug Stimulation in Paralytic Ileus Surgical Therapy Goals Emergency Indications Relative Indications 16.2.8 Specific Therapy for Certain Types of Ileus Paralytic Ileus Conservative Therapy Surgical/Endoscopic Therapy Vascular Ileus Strangulation Ileus Postoperative Ileus Ogilvie’s Syndrome Large Bowel Obstruction Due to Colon Cancer Conservative Therapy Bridge-to-Surgery Primary Resection Gallstone Ileus Volvulus 16.3 Abdominal Compartment Syndrome 16.3.1 Definitions Intra-Abdominal Pressure (IAP) Abdominal Perfusion Pressure (APP) Intra-Abdominal Hypertension (IAH) Abdominal Compartment Syndrome (ACS) 16.3.2 Aetiology Classification of Abdominal Compartment Syndrome (ACS, . Table 16.3) Pathophysiology 16.3.3 Clinical presentation Risk Factors Symptoms 16.3.4 Diagnosis Bladder Pressure Measurement (Gold Standard) Clinical Presentation Imaging 16.3.5 Therapy General Principles of Therapy WSACS Guidelines Supportive Measures Goals Conservative Measures Improvement of Abdominal Wall Compliance Decrease in Intra-Abdominal Volume Surgical Measures Decompressive Laparotomy New Alternatives Temporary Abdominal Closure Definitive Abdominal Closure 16.3.6 Guidelines 16.4 Intestinal Ischemia 16.4.1 General 16.4.2 Acute Intestinal Ischaemia Epidemiology Etiology and Pathogenesis Clinical Presentation Non-Specific Clinical Presentation 3-Phase Clinical Course (Rarely Detectable) Diagnosis Anamnesis Laboratory Tests Diagnostic Imaging Therapy Stabilization Acute Mesenteric Artery Embolism Acute Mesenteric Artery Thrombosis Acute Mesenteric Vein Thrombosis Ischemic Colitis and Nonocclusive Mesenteric Ischemia (NOMI) 16.4.3 Chronic Mesenteric Ischaemia (CMI) Etiology and Pathogenesis Etiology Pathogenesis (= Atherosclerosis) Clinical Presentation Diagnosis Therapy 16.4.4 Guidelines